Hu, B., An, H., Yan, X., Zheng, J., Huang, X., & Li, M. (2019). Traditional Chinese medicine formulation Yanggan Jiedu Sanjie inhibits TGF-β1-induced epithelial-mesenchymal transition and metastatic potential in human hepatocarcinoma Bel-7402 cells. BMC Complement Altern Med.
Citação norma ChicagoHu, Bing, Hong-Mei An, Xia Yan, Jia-Lu Zheng, Xiao-Wei Huang, and Miao Li. "Traditional Chinese Medicine Formulation Yanggan Jiedu Sanjie Inhibits TGF-β1-induced Epithelial-mesenchymal Transition and Metastatic Potential in Human Hepatocarcinoma Bel-7402 Cells." BMC Complement Altern Med 2019.
ציטוט MLAHu, Bing, et al. "Traditional Chinese Medicine Formulation Yanggan Jiedu Sanjie Inhibits TGF-β1-induced Epithelial-mesenchymal Transition and Metastatic Potential in Human Hepatocarcinoma Bel-7402 Cells." BMC Complement Altern Med 2019.